Bullous pemphigoid in an HB virus carrier: Interaction between corticosteroids and HB virus

Journal of Dermatology

Volumn 24, Issue 3, 1997, Pages 179-183

  Inadomi, Toru ^a   Saito, Tamiko ^b   Kaneko, Miki ^b   Hashimoto, Takashi ^c   Suzuki, Hiroyuki ^a  

^a SURUGADAI NIHON UNIVERSITY HOSPITAL   (Japan)

^b NIHON UNIVERSITY   (Japan)

^c KEIO UNIVERSITY   (Japan)

Author keywords

bullous pemphigoid; carrier; HB virus; prednisolone

Indexed keywords

PREDNISOLONE;

ARTICLE; BULLOUS PEMPHIGOID; CASE REPORT; FEMALE; HEPATITIS B; HETEROZYGOTE; HUMAN; LIVER FAILURE; MIDDLE AGED;

CARRIER STATE; FEMALE; HEPATITIS B; HUMANS; LIVER FAILURE; MIDDLE AGED; PEMPHIGOID, BULLOUS; PREDNISOLONE;

EID: 0031089549     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.1997.tb02768.x     Document Type: Article

References (14)

1. Pye RJ,: Bullous pemphigoid, in, Rook A, Wilkinson DS, Ebling FJG, Champion RH, (eds): Textbook of Dermatology, 5th ed, Vol 2, Blackwell Scientific Publications, Oxford, 1992, pp 1647-1652.
2. Lever WF, Lever GS,: Bullous pemphigoid, in: Histopathology of the Skin, 7th ed, JB Lippincott, Philadelphia, 1990, pp 125-130.
3. Takai E, Machida A, Ohnuma H, et al. A solid-phase enzyme immunoassay for the determination of IgM and IgG antibodies against translation products of pre-S1 and pre-S2 regions of hepatitis B virus, J Immunol Methods, 95: 23-30, 1986.
4. Shimizu M,: Prevention of perinatal transmission of hepatitis B virus from hepatitis B antigen positive mothers to their infants, in, Nishioka K, (ed): Hepatitis Viruses and Hepatocellular Carcinoma Approaches through Molecular Biology and Ecology, Academic Press, Tokyo, 1985, p 169.
5. Okamoto H, Yotsumoto S, Akahane Y, et al. Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen, J Virol, 64: 1298-1303, 1990.
6. Akahane Y, Yamanaka T, Suzuki H, et al. Chronic active hepatitis with hepatitis B virus DNA and antibody against e antigen in the serum: Disturbed synthesis and secretion of e antigen from hepatocytes due to a point mutation in the precore region, Gastroenterology, 99: 1113-1119, 1990.
7. Omata M, Ebata M,: Precore mutation and severe hepatitis, Naika, 69: 1148-1152, 1992. (in Japanese)
8. Canalese J, Gove CD, Gimson AE, Wilkinson SP, Wardle EN, Williams R,: Reticuloendothelial system and hepatocytic function in fulminant hepatic failure, Gut, 23: 265-269, 1982.
9. Ohno Y, Shiga J, Mori W,: Selective segmental hepatic necrosis produced by the Shwartzman mechanism in rabbits, Virchows Archiv, 416: 75-80, 1989.
10. Shanks N, McCormick CM, Meaney MJ,: Sex differences in hypothalamic-pituitary-adrenal responding to endotoxin challenge in the neonate: Reversal by gonadectomy, Dev Brain Res, 79: 260-266, 1994.
11. Hill GE, Alonso A, Thiele GM, Robbins RA,: Glucocorticoids blunt neutrophil CD11b surface glycoprotein upregulation during cardiopulmonary bypass in humans, Anesth Analg, 79: 23-27, 1994.
12. Takano S, Arakawa Y, Okubo H, et al. Randomized controlled trial of steroid withdrawal followed by continuous and intermittent administration of natural alpha-interferon for chronic hepatitis B, Int Hepatol Commun, 2: 128-134, 1994.
13. Takano S, Omata M, Yokosuka Ok, Imazeki F, Ohto M,: Effects of antiviral agents on chronic hepatitis B. Analysis using Cox proportional hazard model, Digestive Diseases & Sciences, 37: 1633-1643, 1992.
14. Itoh S, Matsuo S, Oda T, Marutani K, Sasaki K,: Triiodothyronine level and triiodothyronine/thyroxine ratio in HB(e)Ag-positive chronic hepatitis patients treated with prednisolone withdrawal, Digestive Diseases & Sciences, 35: 1110-1114, 1990.